A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)

بواسطة Chen, Yunxin, Gopalakrishnan, Sathish Kumar, Ooi, Melissa, Sultana, Rehena, Lim, Li Hui, Grigoropoulos, Nicholas, Ong, Shin Yeu, Xu, Mingge, Chng, Wee Joo, Goh, Yeow Tee, Nagarajan, Chandramouli
منشور في 2021

Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network

بواسطة Soekojo, Cinnie Yentia, Kim, Kihyun, Huang, Shang-Yi, Chim, Chor-Sang, Takezako, Naoki, Asaoku, Hideki, Kimura, Hideo, Kosugi, Hiroshi, Sakamoto, Junichi, Gopalakrishnan, Sathish Kumar, Nagarajan, Chandramouli, Wei, Yuan, Moorakonda, Rajesh, Lee, Shu Ling, Lee, Je Jung, Yoon, Sung-Soo, Kim, Jin Seok, Min, Chang Ki, Lee, Jae-Hoon, Durie, Brian, Chng, Wee Joo
منشور في 2022